NASDAQ
Adial Pharmaceuticals, Inc. (ADIL) has a free cash flow growth of -21.73% as of Friday, May 29, 2026. This represents a 2543.17% decrease compared to its 12-month average of 0.89%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.